Newcastle University has a long and successful track-record of collaborating with businesses to translate our research into commercial and societal impact.
We rank 16th in the UK for research power out of 154 higher education institutions (Research Excellence Framework 2014). We have top 10 ranking disciplines in:
- computing sciences
- clinical medicine
- biological science
- civil engineering
We deliver research through our Faculties, institutes, Schools and research centres.
We are committed to putting our research and business innovation excellence to work by supporting businesses to find solutions to real-world challenges.
The needs of the older population are often neglected during the design of products and services. Design Network North recognised this and set up an exemplar project with Newcastle University focused on street furniture.
Edinburgh-based Aquamarine Power have designed and built Oyster®, a prototype hydro-electric wave power converter.
Newcastle University Developed a new qualification in Clinical Research for the Department of Health, to equip students with all the skills identified by their strategy.
An innovative partnership between Newcastle University Medical School and a drug development company has facilitated development of drug candidates that are active against infectious diseases and have entered clinical development.
Pioneering research at Newcastle University could lead to a ‘magic bullet’ cure for cancer.
‘E-Health’ is about using the power of internet-based technologies to improve home-based health programmes.
Newcastle University is helping reduce the carbon footprint of the shipping industry through a joint project with private sector partners and industry groups.
Newcastle University, backed by £12.6m funding from the Research Councils UK, has established a Digital Economy Hub to investigate Social Inclusion through the Digital Economy (SiDE).
Newcastle University has spent many years developing a strong relationship with British technology company Dyson.
UK-PBC Stratified Medicine is an exciting new project aimed at transforming the capacity to treat primary biliary cirrhosis (PBC) and to establish a national trial resource.